HSB-3215

N/A

Report date: 2024/01/24 13:18:30

Base Information

Drug NameHSB-3215

Drug Alias NameHSB-3215TH-3215

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-HER2Anti-Receptor tyrosine-protein kinase erbB-3

TargetsReceptor protein-tyrosine kinase erbB-2Receptor tyrosine-protein kinase erbB-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTharimmune Inc

China Registration ClassN/A

Develop Information

Active CompaniesTharimmune Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A